FDA permits emergency use of flu drugs, diagnostic test:

04/27/2009 | Reuters · Wall Street Journal, The

The FDA has signed emergency authorizations for unapproved uses of GlaxoSmithKline's Relenza, Roche Holding's Tamiflu and the rRT-PCR Swine Flu Panel diagnostic test in response to the public health emergency declared amid the swine flu outbreak. The swine flu strain reportedly has infected more than 40 people in the U.S.

View Full Article in:

Reuters · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC